CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) /
The debt of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. over the past 10 years
Chart CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. had liquid cash of $213.77M and total debt of $2.14B: net debt of $1.92B. It had more debt than liquid cash at all 10 year-ends shown. Total debt was highest at the end of fiscal 2022 ($2.71B) and lowest at the end of fiscal 2017 ($1.15B).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 27, 2025 | $213.77M | $2.14B | -$1.92B |
| 2024ended Dec 28, 2024 | $194.61M | $2.24B | -$2.05B |
| 2023ended Dec 30, 2023 | $276.77M | $2.65B | -$2.37B |
| 2022ended Dec 31, 2022 | $233.91M | $2.71B | -$2.47B |
| 2021ended Dec 25, 2021 | $241.21M | $2.66B | -$2.42B |
| 2020ended Dec 26, 2020 | $228.42M | $1.98B | -$1.75B |
| 2019ended Dec 28, 2019 | $238.01M | $1.89B | -$1.65B |
| 2018ended Dec 29, 2018 | $195.44M | $1.67B | -$1.47B |
| 2017ended Dec 30, 2017 | $163.79M | $1.15B | -$981.31M |
| 2016ended Dec 31, 2016 | $117.63M | $1.24B | -$1.12B |
Fiscal years as CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- The revenue of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- The profitability of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- The cash flow of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- All of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s financials, charted
Companies of a similar size
- ROLROLLINS, INC.
- DOCUDOCUSIGN, INC.
- HHyatt Hotels Corp
- FDXFFedEx Freight Holding Company, Inc.
- EXELExelixis Inc
Not investment advice. This page shows what CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.